Table 4.

Changes observed in symptoms after Treatment.

Clinical Symptoms	Group A				Group B			Group C
	BTa	ATb	P valuec		BTa	ATb	P valuec	BTa	ATb	P valuec
Fever	0.45	0	<0.001		0.375	0.025	0.002	0.125	0.025	0.046
Sore throat	0.975	0.05	<0.001		0.4	0.1	0.003	0.3	0.15	0.014
Cough	0.775	0.05	<0.001		0.375	0.05	<0.001	0.425	0.3	0.025
Dyspnea (difficulty in breathing)	0.15	0	0.034		0.225	0.075	0.014	0	0	1.000
Running Nose	0.225	0		0.007	0.3	0.13	0.052	0.1	0.03	0.083
General weakness	0.325	0.2		0.025	0.275	0.075	0.25	0.011	0.15	0.046
Headache	0.075	0		0.083	0	0	1.0	0.08	0.05	0317
Irritability	0.31	0		0.001	0.475	0.1	0.001	0.25	0.175	0.083
Nausea/vomiting	0	0		1	0.15	0.075	0	0.063	0	0.063
Diarrhea	0	0		1	0	0	1	0	0	1
Loss of Taste	0.35	0.1		0.023	0.225	0.05	0.02	0.08	0.1	0.705
Loss of Smell	0.25	0.025		0.007	0.1	0.05	0.157	0.18	0.125	0.317

^aBT before treatment.

^bAT After treatment.

^cWilcoxon Signed Rank test.